rebel Financial rebel Financial
← All Posts

Inspire Medical Systems, Inc.

May 01, 2026 • Author: Phil Ratcliff
Item Proposal Vote
1 Election of Class II Directors
1.01 Gary L. Ellis ✓ For
1.02 Georgia Melenikiotou ✓ For
1.03 Dana G. Mead, Jr. ✓ For
2 Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for 2026. ✓ For
3 Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers. ✓ For
4 Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers. 1 Year
5 Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with the Company's 2029 annual meeting of stockholders. ✓ For
6 Approval of an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan. ✓ For
7 Approval of an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6. ✓ For
Attachments
📄
Inspire_Proxy_Statement.pdf 7.9 MB
📄
Inspire_Annual_Report.pdf 1.8 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.